Copper first accumulates in liver, then announces itself through brain, blood, and cornea.
Reference image for orientation, not a diagnostic studyPeripheral corneal copper forms a Kayser-Fleischer ring, a high-value clue in a young patient with liver or neurologic disease.Imrankabirhossain / Wikimedia Commons (CC BY-SA 4.0). SourceCC BY-SA 4.0
Explain how ATP7B dysfunction impairs biliary copper excretion and ceruloplasmin loading.
Integrate Kayser-Fleischer rings, ceruloplasmin, urine copper, hepatic copper, genetics, and clinical findings without relying on one test.
Select chelation, zinc, monitoring, plasma exchange bridging, or liver transplantation according to presentation.
Bilirubin route
Follow the pigment without skipping a compartment
The route distinguishes production, transport, conjugation, excretion, and downstream clues.
Quick check
A 19-year-old develops dysarthria, a wing-beating tremor, depression, and elevated aminotransferases. Slit-lamp examination shows Kayser-Fleischer rings; ceruloplasmin is low and 24-hour urine copper is elevated.
Which molecular defect best explains the syndrome?
Reason it through
Which organs are linked in the stem?Liver, basal ganglia, mood, and cornea.
Which metal creates that combination?Copper.
Which hepatocyte transporter handles it?ATP7B.
Young liver disease plus movement or psychiatric change is a copper question.
Recognize the many faces of Wilson disease
The phenotype changes with where copper has accumulated and how abruptly it is released.
Children often present with hepatic disease, while adolescents and adults may show hepatic, neurologic, psychiatric, or mixed disease. Tremor, dystonia, dysarthria, parkinsonism, personality change, depression, and psychosis are all possible.
Coombs-negative intravascular hemolysis can occur when copper is abruptly released from injured hepatocytes, especially in acute liver failure. Kayser-Fleischer rings are common in neurologic disease but less sensitive in isolated hepatic presentations.
Compare the major presentations.
Steatosis, hepatitis, autoimmune-like injury, cirrhosis, or acute liver failure may occur.
Tremor, dystonia, dysarthria, gait change, mood disorder, personality change, or psychosis can dominate.
Coombs-negative hemolysis with jaundice can signal a copper surge and severe hepatic injury.
Kayser-Fleischer rings reflect copper in Descemet membrane and strongly support the diagnosis in the right phenotype.
Wilson disease rarely reads the textbook in only one organ.
Follow copper from diet to toxic spill
ATP7B normally routes copper toward bile and ceruloplasmin.
Dietary copper reaches hepatocytes, where ATP7B helps incorporate copper into apoceruloplasmin and moves excess copper into bile for excretion.
When ATP7B function is lost, hepatic copper accumulates, injures hepatocytes, and spills into blood. Non-ceruloplasmin-bound copper then deposits in brain, cornea, kidney, and other tissues and can damage red cells.
Order the disease mechanism.
Portal blood delivers copper to the liver.
ATP7B participates in ceruloplasmin loading and intracellular trafficking.
Biliary elimination is the major route for copper balance.
Failed export expands the toxic hepatic copper pool.
Copper reaches basal ganglia, cornea, kidney, and erythrocytes.
Use copper measurements as context, not commandments
Thresholds support a diagnosis only when the collection and phenotype make sense.
Basal 24-hour urine copper above about 100 micrograms per day supports symptomatic Wilson disease, while values above about 40 micrograms per day may be meaningful in asymptomatic patients or children. Complete urine collection and avoidance of copper contamination matter.
Hepatic copper above about 250 micrograms per gram dry weight strongly supports the diagnosis, but uneven distribution can cause sampling error and chronic cholestasis can raise hepatic copper from other causes.
Rank the findings by diagnostic weight in a compatible patient.
Do not diagnose Wilson disease from ceruloplasmin alone
Wilson disease is a weighted evidence diagnosis.
Ceruloplasmin is often low, but normal values occur in some affected patients and low values can occur with infancy, severe liver failure, protein loss, malnutrition, or heterozygosity. It is an acute-phase reactant and can rise with inflammation or estrogen exposure.
The diagnostic set includes clinical phenotype, slit-lamp examination, serum studies, basal 24-hour urine copper, ATP7B testing, and hepatic copper when noninvasive evidence is discordant. Sampling variability and cholestasis can complicate hepatic copper interpretation.
Select the best diagnostic principle.
Ceruloplasmin changes probability; it does not close the case.
Map copper across organs
The same metal produces different clues in each compartment.
Hepatic accumulation can cause steatosis, inflammation, fibrosis, cirrhosis, or acute failure. Basal ganglia deposition produces movement abnormalities, while corneal deposition forms Kayser-Fleischer rings at Descemet membrane.
Renal tubular injury can cause aminoaciduria or nephrolithiasis, and circulating copper can trigger Coombs-negative hemolysis. Brain MRI may show basal ganglia, thalamic, brainstem, or white matter abnormalities but is not diagnostic alone.
Place each finding in the correct part of the pathway.
Copper accumulation begins here and may produce chronic disease or acute failure.
Deposition produces tremor, dystonia, dysarthria, and other movement disorders.
Copper forms Kayser-Fleischer rings detected by slit lamp.
Copper can lyse red cells and injure renal tubules.
Remove copper for life and transplant failing liver
Initial therapy depends on symptoms, organ burden, and the urgency of decoppering.
Symptomatic patients generally begin a copper chelator such as trientine or D-penicillamine under expert monitoring. Zinc reduces intestinal copper absorption and is used for selected presymptomatic patients or maintenance after decoppering; regimen choice and transition require specialist oversight because undertreatment and abrupt interruption can worsen disease.
Wilson-associated acute liver failure requires immediate transplant-center referral. Chelation and high-volume plasma exchange may be used as bridge therapy in selected patients, but encephalopathy or a poor prognostic score supports urgent liver transplantation. Lifelong treatment continues through pregnancy with individualized dosing rather than abrupt cessation.
Reveal the treatment decision for each branch.
Symptomatic hepatic or neurologic disease
Start expert-directed chelation and monitor clinical response, blood counts, urinalysis, liver tests, and copper excretion.
Rapid decoppering must be balanced against toxicity and possible neurologic worsening.
Presymptomatic disease or stable maintenance
Use zinc or a chelator according to disease status and prior response.
The goal is durable negative or neutral copper balance.
Apparent treatment failure
Check adherence, dosing, urinary copper pattern, and disease progression before changing agents.
Poor adherence can mimic pharmacologic failure.
Acute liver failure
Transfer for urgent transplantation assessment and consider plasma exchange as a bridge.
Medical treatment alone is often insufficient once severe failure is established.
Wilson disease generally requires lifelong treatment even after copper indices improve.
Key laboratory clue
Choose the compartment that explains the pattern
Localize the defect in bilirubin handling before naming a syndrome.
Which molecular defect best explains the syndrome?
Key finding. A 19-year-old develops dysarthria, a wing-beating tremor, depression, and elevated aminotransferases. Slit-lamp examination shows Kayser-Fleischer rings; ceruloplasmin is low and 24-hour urine copper is elevated.
Answer. Biallelic ATP7B dysfunction with impaired biliary copper excretion
Why. ATP7B failure traps copper in hepatocytes and later permits deposition in brain and cornea.
Board rule. Young liver disease plus movement or psychiatric change is a copper question.
Stage 1 of 3: Overview
Overview
Wilson Disease
ATP7B normally routes copper toward bile and ceruloplasmin.
Step by step
Follow copper from diet to toxic spill
1Absorb dietary copperPortal blood delivers copper to the liver.
2Handle copper in hepatocytesATP7B participates in ceruloplasmin loading and intracellular trafficking.
3Excrete excess into bileBiliary elimination is the major route for copper balance.
4Accumulate and injure liverFailed export expands the toxic hepatic copper pool.
5Spill into extrahepatic tissuesCopper reaches basal ganglia, cornea, kidney, and erythrocytes.
Clinical takeaway
Why it mattersWhen ATP7B function is lost, hepatic copper accumulates, injures hepatocytes, and spills into blood. Non-ceruloplasmin-bound copper then deposits in brain, cornea, kidney, and other tissues and can damage red cells.
RememberYoung liver disease plus movement or psychiatric change is a copper question.
Interpret the bilirubin patterns
Five patients test multimodal diagnosis, normal ceruloplasmin, acute liver failure, presymptomatic treatment, and chelator selection.
Cross out the wrong compartment and highlight the clue that localizes bilirubin handling. Each case follows the route step by step.
A 14-year-old has hepatitis, Coombs-negative hemolytic anemia, low ceruloplasmin, elevated 24-hour urine copper, and Kayser-Fleischer rings.
Which diagnosis is most likely?
Reason it through
Why is the anemia not immune?The direct antiglobulin test is negative.
What can free copper do to red cells?It causes oxidative intravascular hemolysis.
Which clue closes the metal identity?Kayser-Fleischer rings support copper deposition.
Hepatitis plus nonimmune hemolysis is a Wilson alarm.
Why is the anemia not immune?What can free copper do to red cells?
Why is the anemia not immune?The direct antiglobulin test is negative.
What can free copper do to red cells?It causes oxidative intravascular hemolysis.
Which clue closes the metal identity?Kayser-Fleischer rings support copper deposition.
A 27-year-old develops dystonia, dysarthria, and personality change. Ceruloplasmin is within the laboratory reference range, but slit-lamp examination shows Kayser-Fleischer rings.
What is the most appropriate next step?
Reason it through
Is ceruloplasmin perfectly sensitive?No; some affected patients have normal values.
What raises the pretest probability?A young-onset movement and psychiatric syndrome.
What objective clue adds major weight?Kayser-Fleischer rings.
A normal carrier protein cannot erase a copper phenotype.
Is ceruloplasmin perfectly sensitive?What raises the pretest probability?
Is ceruloplasmin perfectly sensitive?No; some affected patients have normal values.
What raises the pretest probability?A young-onset movement and psychiatric syndrome.
What objective clue adds major weight?Kayser-Fleischer rings.
A 20-year-old has acute liver failure with encephalopathy, rapidly rising bilirubin, modest aminotransferase elevation, low alkaline phosphatase, renal injury, and Coombs-negative hemolysis.
What is the best immediate management principle?
Reason it through
What syndrome does encephalopathy establish?Acute liver failure.
Why does hemolysis matter here?It suggests a large release of toxic copper.
What treatment changes survival?Urgent liver transplantation.
Wilson acute liver failure is a transplant emergency with copper bridge therapy.
What syndrome does encephalopathy establish?Why does hemolysis matter here?
What syndrome does encephalopathy establish?Acute liver failure.
Why does hemolysis matter here?It suggests a large release of toxic copper.
What treatment changes survival?Urgent liver transplantation.
An asymptomatic sibling of a patient with Wilson disease has biallelic pathogenic ATP7B variants, elevated urine copper, and no organ damage.
What is the correct treatment principle?
Reason it through
Is the genotype disease-causing?Yes; both ATP7B alleles are pathogenic.
Is copper handling already abnormal?Yes; urine copper is elevated.
Why treat before symptoms?Copper injury can be prevented but may not be fully reversible.
Presymptomatic Wilson disease is treated, not watched into damage.
Is the genotype disease-causing?Is copper handling already abnormal?
Is the genotype disease-causing?Yes; both ATP7B alleles are pathogenic.
Is copper handling already abnormal?Yes; urine copper is elevated.
Why treat before symptoms?Copper injury can be prevented but may not be fully reversible.
A patient with symptomatic hepatic Wilson disease has stable renal function and no prior anti-copper therapy. The goal is active decoppering.
Which initial drug class is generally preferred?
Reason it through
Is the patient symptomatic?Yes; liver disease is established.
What is the therapeutic goal?Remove accumulated copper.
Which class directly binds copper for excretion?Copper chelators.
Symptomatic burden calls for decoppering, not absorption blockade alone.
Is the patient symptomatic?What is the therapeutic goal?
Is the patient symptomatic?Yes; liver disease is established.
What is the therapeutic goal?Remove accumulated copper.
Which class directly binds copper for excretion?Copper chelators.
Rapid review
Three questions to check
Which molecular defect best explains the syndrome?
Biallelic ATP7B dysfunction with impaired biliary copper excretion. ATP7B failure traps copper in hepatocytes and later permits deposition in brain and cornea.
Resident physician and founding medical reviewer at Bone Wizardry, focused on clinical accuracy, clear diagnostic reasoning, and practical board-oriented teaching across the curriculum.
